The Morning Echo

Nonalcoholic Steatohepatitis (NASH): Understanding a Serious Fatty Liver Disease

Nonalcoholic steatohepatitis (NASH) is a progressive liver condition that develops when fat buildup in the liver causes inflammation and cellular damage. It belongs to a broader group of liver disorders known as nonalcoholic fatty liver disease (NAFLD), which occurs in people who drink little or no alcohol.

NASH represents the more severe stage of fatty liver disease and can lead to long-term liver complications if not properly managed.

What Is NASH?

NASH occurs when excess fat accumulates in liver cells and triggers inflammation. Over time, this inflammation damages liver tissue and may result in fibrosis (scarring), cirrhosis, or even liver cancer in advanced cases.

Protein Chips: How Tiny Arrays Are Transforming Disease Detection and Drug Research

Protein chips, also known as protein microarrays, are powerful laboratory tools designed to analyze proteins on a large scale. While DNA testing tells us what genes are present, proteins reveal what cells are actively doing at any given moment.

Because proteins control most biological functions — from immune responses to cell signaling — studying them provides direct insight into disease activity, treatment effectiveness, and overall cellular health. Protein chips allow researchers to examine hundreds or even thousands of protein interactions simultaneously using only a small biological sample.